Related Experiment Video
Updated: May 26, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
ParalichenysinDY4, a novel bacteriocin-like substance, is employed to control Clostridium perfringens
Haiyan Wang1, Linkang Wang1, Fenqiang Zhang1
1National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, Huazhong Agricultural University, Wuhan, Hubei, People's Republic of China; College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, People's Republic of China; Key Laboratory of Preventive Veterinary Medicine in Hubei Province, Cooperative Innovation Center for Sustainable Pig Production, Wuhan, Hubei, People's Republic of China.
Abstract:
Clostridium perfringens (C. perfringens) is an important pathogen that contributes to human and animal disease. At present, antibiotic therapy is one of the most effective strategies for C. perfringens. However, with the rise of antibacterial resistance, new agents with novel mechanisms of action are urgently needed. Bacteriocins are recognized as a viable alternative to antibiotics. In this study, the bacteriocin-like substance ParalichenysinDY4, derived from the Bacillus paralicheniformis (B. paralicheniformis) DY4 strain, is investigated as a potential alternative for combating Clostridium perfringens. The substance was isolated from B. paralicheniformis DY4 fermentation broth through a series of purification steps including methanol extraction, gel filtration, and high-performance liquid chromatography. Mass spectrometry analysis of ParalichenysinDY4 revealed that the detected peptide sequences did not match any previously known bacteriocins, indicating it is a novel bacteriocin-like substance. The novel bacteriocin-like substance exhibits effective antibacterial activity and broad antimicrobial spectrum against C. perfringens. Subsequent analyses utilizing methodologies including flow cytometry and scanning electron microscopy suggest that its mechanism of action is linked to its effects on the cell membrane. At the same time, due to its exceptional stability, safety, and efficient ability to remove pathogens both in vitro and in vivo, ParalichenysinDY4 holds promise as a valuable natural antimicrobial agent.
Insights
A novel bacteriocin-like substance, ParalichenysinDY4, effectively combats Clostridium perfringens by targeting its cell membrane. This discovery offers a promising natural alternative to antibiotics for treating C. perfringens infections.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Clostridium perfringens is a significant pathogen causing human and animal diseases.
- Antibiotic resistance necessitates the development of novel antimicrobial agents.
- Bacteriocins present a viable alternative to conventional antibiotics.
Purpose of the Study:
- To investigate the potential of ParalichenysinDY4, a novel bacteriocin-like substance from Bacillus paralicheniformis DY4, as an alternative agent against Clostridium perfringens.
- To characterize ParalichenysinDY4 and elucidate its mechanism of action.
- To evaluate the efficacy and safety of ParalichenysinDY4 in vitro and in vivo.
Main Methods:
- Isolation and purification of ParalichenysinDY4 using methanol extraction, gel filtration, and HPLC.
- Mass spectrometry for peptide sequence analysis.
- Antibacterial activity assays, flow cytometry, and scanning electron microscopy to determine mechanism of action.
Main Results:
- ParalichenysinDY4 was identified as a novel bacteriocin-like substance with no prior known matches.
- The substance demonstrated effective antibacterial activity and a broad antimicrobial spectrum against Clostridium perfringens.
- Mechanism of action involves disruption of the bacterial cell membrane.
Conclusions:
- ParalichenysinDY4 is a novel, potent antimicrobial agent against Clostridium perfringens.
- Its cell membrane-targeting mechanism and stability make it a promising candidate for natural antimicrobial therapies.
- ParalichenysinDY4 shows potential for both in vitro and in vivo applications in combating C. perfringens.
Related Concept Videos
Methods for Controlling Microbial Growth
Biological Methods for Microbial Control
Gene Regulation in Microbial Communities: Quorum Sensing
Production of Antibiotics
Production of Biopesticides
Bacterial Toxins

